
Prince Akwasi Mensah
Examiner (ID: 16550, Phone: (571)270-7183 , Office: P/2474 )
| Most Active Art Unit | 2474 |
| Art Unit(s) | 2416, 2474 |
| Total Applications | 590 |
| Issued Applications | 431 |
| Pending Applications | 63 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3833083
[patent_doc_number] => 05712262
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-27
[patent_title] => 'Use of sphingosine-1-phosphate to suppress programmed cell death'
[patent_app_type] => 1
[patent_app_number] => 8/754323
[patent_app_country] => US
[patent_app_date] => 1996-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1966
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/712/05712262.pdf
[firstpage_image] =>[orig_patent_app_number] => 754323
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/754323 | Use of sphingosine-1-phosphate to suppress programmed cell death | Nov 20, 1996 | Issued |
Array
(
[id] => 3887283
[patent_doc_number] => 05723501
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Pharmaceutical compositions containing 3-IODO-1,2-propanediol having mucolytic activity'
[patent_app_type] => 1
[patent_app_number] => 8/754611
[patent_app_country] => US
[patent_app_date] => 1996-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2303
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723501.pdf
[firstpage_image] =>[orig_patent_app_number] => 754611
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/754611 | Pharmaceutical compositions containing 3-IODO-1,2-propanediol having mucolytic activity | Nov 19, 1996 | Issued |
Array
(
[id] => 3762331
[patent_doc_number] => 05852032
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Method of treating nicotine dependence'
[patent_app_type] => 1
[patent_app_number] => 8/752955
[patent_app_country] => US
[patent_app_date] => 1996-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2389
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/852/05852032.pdf
[firstpage_image] =>[orig_patent_app_number] => 752955
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/752955 | Method of treating nicotine dependence | Nov 19, 1996 | Issued |
Array
(
[id] => 4052855
[patent_doc_number] => 05932614
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Sulfonic stilbene compounds in the treatment of viral diseases'
[patent_app_type] => 1
[patent_app_number] => 8/740905
[patent_app_country] => US
[patent_app_date] => 1996-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6613
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932614.pdf
[firstpage_image] =>[orig_patent_app_number] => 740905
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/740905 | Sulfonic stilbene compounds in the treatment of viral diseases | Nov 4, 1996 | Issued |
Array
(
[id] => 3874379
[patent_doc_number] => 05824667
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-20
[patent_title] => 'Composition for contraception'
[patent_app_type] => 1
[patent_app_number] => 8/742147
[patent_app_country] => US
[patent_app_date] => 1996-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2619
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/824/05824667.pdf
[firstpage_image] =>[orig_patent_app_number] => 742147
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/742147 | Composition for contraception | Oct 30, 1996 | Issued |
| 08/736356 | COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (EH) LEVELS AND REDUCE ORAL PUTREFACTION, ORAL MALODOR, GINGIVITIS AND PERIODONTITIS | Oct 22, 1996 | Abandoned |
Array
(
[id] => 3770454
[patent_doc_number] => 05733919
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-31
[patent_title] => 'Compositions for inhibiting platelet aggregation'
[patent_app_type] => 1
[patent_app_number] => 8/735878
[patent_app_country] => US
[patent_app_date] => 1996-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4069
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/733/05733919.pdf
[firstpage_image] =>[orig_patent_app_number] => 735878
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/735878 | Compositions for inhibiting platelet aggregation | Oct 22, 1996 | Issued |
Array
(
[id] => 3906674
[patent_doc_number] => 05898035
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-27
[patent_title] => 'Formulations of haloalkylamines and local anesthetic and methods for the treatment of reflex sympathetic dystrophy (RSD)'
[patent_app_type] => 1
[patent_app_number] => 8/727624
[patent_app_country] => US
[patent_app_date] => 1996-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4302
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/898/05898035.pdf
[firstpage_image] =>[orig_patent_app_number] => 727624
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/727624 | Formulations of haloalkylamines and local anesthetic and methods for the treatment of reflex sympathetic dystrophy (RSD) | Oct 21, 1996 | Issued |
Array
(
[id] => 4028315
[patent_doc_number] => 05902811
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-11
[patent_title] => 'Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions'
[patent_app_type] => 1
[patent_app_number] => 8/732660
[patent_app_country] => US
[patent_app_date] => 1996-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3940
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/902/05902811.pdf
[firstpage_image] =>[orig_patent_app_number] => 732660
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/732660 | Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions | Oct 14, 1996 | Issued |
Array
(
[id] => 3860466
[patent_doc_number] => 05792799
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-11
[patent_title] => 'Parenteral delivery of MAO A inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/729290
[patent_app_country] => US
[patent_app_date] => 1996-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4368
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/792/05792799.pdf
[firstpage_image] =>[orig_patent_app_number] => 729290
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/729290 | Parenteral delivery of MAO A inhibitors | Oct 9, 1996 | Issued |
Array
(
[id] => 3770134
[patent_doc_number] => 05733900
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-31
[patent_title] => 'Percutaneous administration base composition and percutaneous administration medicinal composition comprising said base composition and medicine'
[patent_app_type] => 1
[patent_app_number] => 8/702449
[patent_app_country] => US
[patent_app_date] => 1996-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3581
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/733/05733900.pdf
[firstpage_image] =>[orig_patent_app_number] => 702449
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/702449 | Percutaneous administration base composition and percutaneous administration medicinal composition comprising said base composition and medicine | Sep 25, 1996 | Issued |
Array
(
[id] => 3983539
[patent_doc_number] => 05958919
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Treatment of presymptomatic alzheimer\'s disease to prevent neuronal degeneration'
[patent_app_type] => 1
[patent_app_number] => 8/710727
[patent_app_country] => US
[patent_app_date] => 1996-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34877
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958919.pdf
[firstpage_image] =>[orig_patent_app_number] => 710727
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/710727 | Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration | Sep 19, 1996 | Issued |
Array
(
[id] => 4058484
[patent_doc_number] => 05863927
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-26
[patent_title] => 'Dextromethorphan and an oxidase inhibitor for treating intractable conditions'
[patent_app_type] => 1
[patent_app_number] => 8/464792
[patent_app_country] => US
[patent_app_date] => 1996-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9106
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/863/05863927.pdf
[firstpage_image] =>[orig_patent_app_number] => 464792
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464792 | Dextromethorphan and an oxidase inhibitor for treating intractable conditions | Sep 18, 1996 | Issued |
Array
(
[id] => 3840401
[patent_doc_number] => 05744498
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'Inhibiting growth and spread of malignancy and retarding DNA breaks'
[patent_app_type] => 1
[patent_app_number] => 8/714656
[patent_app_country] => US
[patent_app_date] => 1996-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 1770
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744498.pdf
[firstpage_image] =>[orig_patent_app_number] => 714656
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/714656 | Inhibiting growth and spread of malignancy and retarding DNA breaks | Sep 15, 1996 | Issued |
Array
(
[id] => 4032272
[patent_doc_number] => 05994372
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Peripherally active anti-hyperalgesic opiates'
[patent_app_type] => 1
[patent_app_number] => 8/712881
[patent_app_country] => US
[patent_app_date] => 1996-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 46461
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/994/05994372.pdf
[firstpage_image] =>[orig_patent_app_number] => 712881
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/712881 | Peripherally active anti-hyperalgesic opiates | Sep 11, 1996 | Issued |
Array
(
[id] => 4086555
[patent_doc_number] => 06025360
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Use of theophylline for the manufacture of a medicament for the treatment of asthma'
[patent_app_type] => 1
[patent_app_number] => 8/652495
[patent_app_country] => US
[patent_app_date] => 1996-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4080
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025360.pdf
[firstpage_image] =>[orig_patent_app_number] => 652495
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/652495 | Use of theophylline for the manufacture of a medicament for the treatment of asthma | Sep 5, 1996 | Issued |
Array
(
[id] => 3772600
[patent_doc_number] => 05756550
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Method of treatment of parkinson\'s disease'
[patent_app_type] => 1
[patent_app_number] => 8/708500
[patent_app_country] => US
[patent_app_date] => 1996-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 979
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756550.pdf
[firstpage_image] =>[orig_patent_app_number] => 708500
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/708500 | Method of treatment of parkinson's disease | Sep 4, 1996 | Issued |
Array
(
[id] => 3876015
[patent_doc_number] => 05713738
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-03
[patent_title] => 'Method for whitening teeth'
[patent_app_type] => 1
[patent_app_number] => 8/708527
[patent_app_country] => US
[patent_app_date] => 1996-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4157
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/713/05713738.pdf
[firstpage_image] =>[orig_patent_app_number] => 708527
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/708527 | Method for whitening teeth | Sep 4, 1996 | Issued |
Array
(
[id] => 4097222
[patent_doc_number] => 06096772
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => 'Use of Angiotensin II type 1 receptor antagonists in the treatment of dyspeptic symptoms'
[patent_app_type] => 1
[patent_app_number] => 8/702522
[patent_app_country] => US
[patent_app_date] => 1996-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1345
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096772.pdf
[firstpage_image] =>[orig_patent_app_number] => 702522
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/702522 | Use of Angiotensin II type 1 receptor antagonists in the treatment of dyspeptic symptoms | Aug 27, 1996 | Issued |
Array
(
[id] => 3927706
[patent_doc_number] => 05877173
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'Preventing neuronal degeneration in Alzheimer\'s disease'
[patent_app_type] => 1
[patent_app_number] => 8/704093
[patent_app_country] => US
[patent_app_date] => 1996-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 31439
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/877/05877173.pdf
[firstpage_image] =>[orig_patent_app_number] => 704093
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/704093 | Preventing neuronal degeneration in Alzheimer's disease | Aug 27, 1996 | Issued |